🔗 Share this article

A shadow economy for unapproved slimming drugs is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.

Investigational Drug Gaining Popularity Online

The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are encouraged to message these accounts directly for supplier links, while also receiving discount codes.

Active Trade on Social Networks

Separately, a flourishing trade exists on Telegram, where groups with numerous of participants share “before and after” images, injection guides and claims of next-day British shipping. Sellers promote the drug there before redirecting customers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Professionals Express Concerns

However, doctors and pharmacists have warned that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to users administering products of uncertain source.

Some professionals stated the popularity for retatrutide could be connected to the rising cost of approved slimming products such as Mounjaro.

Legal Status and Enforcement

Marketing the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the British medical regulations.

Some influencers try to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate medicines, advertising, and consumer regulations, potentially leading to penalties, prosecution or prison.

Service Response and Content Removal

According to the social media company, the platform has taken down problematic content and banned related hashtags and query recommendations. The organization said it was dedicated to keeping the service safe and allocating resources in enhancing compliance measures.

Online Trading Operations

Research also found communities with up to 9,000 participants selling the experimental drug using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately displays groups with thousands of users, filled with images of slimming results, positive reviews and detailed instructions for mixing or administering at home.

Within moments of entering one community, a vendor posted WhatsApp details, where most purchases occur. The vendor provided an instruction manual and promised delivery within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about weight, medical conditions or previous experience.

Item Information and Costs

Within these communities, messages show black plastic packages with Royal Mail labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20 milligrams. When asked how much time a pen should last, vendors give contradictory answers varying between a several days to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for Telegram said it actively moderated harmful material on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting materials they can’t verify. Although the science behind retatrutide is valid, these online versions may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit injections are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she said.

Her team has previously encountered patients injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or communication platforms is taking chances with your health,” stated Wyllie. “These materials could be contaminated or improperly measured.”

Producer Position

A spokesperson from Eli Lilly said the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company investigational substance not yet authorized … may expose patients to potentially serious medical dangers”.